Table 5 Summary of studies assessing cost burden and healthcare resource utilisation in patients with JoRRP
Study | Country | Year of data collection | Parameter | Value [cost year] |
|---|---|---|---|---|
Studies presenting cost data in patients with JoRRP | ||||
Bishai 2000 | US | 1994 | Annual medical costs | $42–67 m USD [NR] |
Estimated cost per case | $29,946 USD [NR] | |||
Chesson 2012 | US | 2004–2007 | Annual medical costs | $123 m USD [2010] |
Cost per case | Mean (range): 150,000 (72,000–387,000) USD [2010] | |||
Derkay 1995 | US | 1993–1994 | Total cost of surgical procedures | $109 m USD [NR] |
Per surgical procedure | $6,593 USD [NR | |||
Narasimhan 2012 | UK | 2005–2011 | Summative treatment cost among 14 patients | £225,000 [NR] |
Tam 2020 | US | 2011–2014 and 2008–2012 | Medical cost in the first 2 years after diagnosis for patients with newly diagnosed JoRRP | Approx. $76,000 USD [2015] (Medicaid patients) |
Approx. $59,000 USD [2015] (privately insured) | ||||
Studies presenting resource data in patients with JoRRP | ||||
Armstrong 1999 | US | 1997–1998 | Annual surgical treatments | Mean (range): 4.4 (0.2–19.3) |
Bishai 2000 | US | 1994 | Number of office visits (per surgery) | Mean (range): 3 (2.4–2.6) |
Derkay 1995 | US | 1993–1994 | Lifetime papilloma operations | 11–20 operations: 21% 21–40 operations: 16% 41–100 operations: 10% > 100 operations: 7% |
Reeves 2003 | US | 1996–2002 | Annual surgical treatments | Mean (range): 5.1 (0.4–21.5) |
Amiling 2021 | US | 2015–2020 | Lifetime surgeries | Median (IQR): 6 (3–13) |
So 2022 | US | NR | RRP-related healthcare visit | 0–2 visits: 84% 3–5 visits: 16% |
Nogueira 2021 | Brazil | 2008–2015 | Number of surgeries | Mean (SD): 7.0 (5.71) |
Omland 2014 | Norway | 1987–2009 | Annual surgical treatment | Median (IQR): 1.2 (0.5–3.4) Mean (SD): 2.0 (2.1) |